ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 135 filers reported holding ASCENDIS PHARMA A/S in Q2 2019. The put-call ratio across all filers is 0.27 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,111,000 | -44.8% | 18,334 | -43.5% | 1.49% | -44.7% |
| Q1 2019 | $3,823,000 | +55.6% | 32,477 | -17.2% | 2.69% | +38.8% |
| Q4 2018 | $2,457,000 | -9.9% | 39,217 | +1.9% | 1.94% | +8.5% |
| Q3 2018 | $2,727,000 | +1.1% | 38,486 | -5.0% | 1.78% | -0.2% |
| Q2 2018 | $2,696,000 | -12.2% | 40,528 | -13.6% | 1.79% | -18.4% |
| Q1 2018 | $3,069,000 | +50.7% | 46,933 | -7.6% | 2.19% | +25.5% |
| Q4 2017 | $2,036,000 | -6.2% | 50,813 | -15.1% | 1.75% | +1.7% |
| Q3 2017 | $2,171,000 | +31.6% | 59,876 | +0.7% | 1.72% | +17.8% |
| Q2 2017 | $1,650,000 | -29.4% | 59,455 | -28.7% | 1.46% | -33.9% |
| Q1 2017 | $2,336,000 | +10.1% | 83,411 | -20.4% | 2.20% | +5.6% |
| Q4 2016 | $2,121,000 | – | 104,793 | – | 2.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |